BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Breast cancer AND NRAS, N-ras, 4893, ENSG00000213281, P01111, NRAS1 AND Prognosis
29 results:

  • 1. Genetic Aspects of Conjunctival Melanoma: A Review.
    Chang E; Demirci H; Demirci FY
    Genes (Basel); 2023 Aug; 14(9):. PubMed ID: 37761808
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Targeting anillin inhibits tumorigenesis and tumor growth in hepatocellular carcinoma via impairing cytokinesis fidelity.
    Chen J; Li Z; Jia X; Song W; Wu H; Zhu H; Xuan Z; Du Y; Zhu X; Song G; Dong H; Bian S; Wang S; Zhao Y; Xie H; Zheng S; Song P
    Oncogene; 2022 May; 41(22):3118-3130. PubMed ID: 35477750
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. KRAS mutation as a predictor of insufficient trastuzumab efficacy and poor prognosis in HER2-positive advanced gastric cancer.
    Shimozaki K; Shinozaki E; Yamamoto N; Imamura Y; Osumi H; Nakayama I; Wakatsuki T; Ooki A; Takahari D; Ogura M; Chin K; Watanabe M; Yamaguchi K
    J Cancer Res Clin Oncol; 2023 Mar; 149(3):1273-1283. PubMed ID: 35438321
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Molecular Spectra and Frequency Patterns of Somatic Mutations in Arab Women with breast cancer.
    Al-Shamsi HO; Abu-Gheida I; Abdulsamad AS; AlAwadhi A; Alrawi S; Musallam KM; Arun B; Ibrahim NK
    Oncologist; 2021 Nov; 26(11):e2086-e2089. PubMed ID: 34327780
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Whole-genome Sequencing of Follicular Thyroid Carcinomas Reveal Recurrent Mutations in MicroRNA Processing Subunit DGCR8.
    Paulsson JO; Rafati N; DiLorenzo S; Chen Y; Haglund F; Zedenius J; Juhlin CC
    J Clin Endocrinol Metab; 2021 Oct; 106(11):3265-3282. PubMed ID: 34171097
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Significant impact of circulating tumour DNA mutations on survival in metastatic breast cancer patients.
    Muendlein A; Geiger K; Gaenger S; Dechow T; Nonnenbroich C; Leiherer A; Drexel H; Gaumann A; Jagla W; Winder T; Mayer F; Decker T
    Sci Rep; 2021 Mar; 11(1):6761. PubMed ID: 33762647
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Primary Mucinous Cystadenocarcinoma of the breast: A Rare Case Report With Review of Literature.
    Jain E; Kumar A; Jain R; Sharma S
    Int J Surg Pathol; 2021 Oct; 29(7):740-746. PubMed ID: 33635116
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. The role of amplified in breast cancer 1 in breast cancer: A meta-analysis.
    Hou J; Liu J; Yuan M; Meng C; Liao J
    Medicine (Baltimore); 2020 Nov; 99(46):e23248. PubMed ID: 33181714
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Induction of PIK3CA alterations during neoadjuvant letrozole may improve outcome in postmenopausal breast cancer patients.
    Skriver SK; Jensen MB; Eriksen JO; Ahlborn LB; Knoop AS; Rossing M; Ejlertsen B; Laenkholm AV
    Breast Cancer Res Treat; 2020 Nov; 184(1):123-133. PubMed ID: 32748297
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Clinicopathological study of intraductal carcinoma of the salivary gland, with emphasis on the apocrine type.
    Hsieh MS; Lee YH; Jin YT; Kuo YJ
    Virchows Arch; 2020 Oct; 477(4):581-592. PubMed ID: 32383006
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Post-radiotherapy vascular lesions of the breast: immunohistochemical and molecular features of 74 cases with long-term follow-up and literature review.
    Corradini AG; Asioli S; Morandi L; Brotto M; Righi A; Iommi M; Agostinelli C; Rucci P; Asioli S; Sapino A; Viale G; Foschini MP
    Histopathology; 2020 Aug; 77(2):293-302. PubMed ID: 32043616
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Prevalence, prognosis and predictive status of HER2 amplification in anti-EGFR-resistant metastatic colorectal cancer.
    Wang G; He Y; Sun Y; Wang W; Qian X; Yu X; Pan Y
    Clin Transl Oncol; 2020 Jun; 22(6):813-822. PubMed ID: 31587152
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. TERT Promoter Mutation Spatial Heterogeneity in a Metastatic Follicular Thyroid Carcinoma: Implications for Clinical Work-Up.
    Stenman A; Hysek M; Jatta K; Bränström R; Darai-Ramqvist E; Paulsson JO; Wang N; Larsson C; Zedenius J; Juhlin CC
    Endocr Pathol; 2019 Sep; 30(3):246-248. PubMed ID: 31154561
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Survival and prognostic factors in surgically treated brain metastases.
    Kavouridis VK; Harary M; Hulsbergen AFC; Lo YT; Reardon DA; Aizer AA; Iorgulescu JB; Smith TR
    J Neurooncol; 2019 Jun; 143(2):359-367. PubMed ID: 30989623
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. A large collection of integrated genomically characterized patient-derived xenografts highlighting the heterogeneity of triple-negative breast cancer.
    Coussy F; de Koning L; Lavigne M; Bernard V; Ouine B; Boulai A; El Botty R; Dahmani A; Montaudon E; Assayag F; Morisset L; Huguet L; Sourd L; Painsec P; Callens C; Chateau-Joubert S; Servely JL; Larcher T; Reyes C; Girard E; Pierron G; Laurent C; Vacher S; Baulande S; Melaabi S; Vincent-Salomon A; Gentien D; Dieras V; Bieche I; Marangoni E
    Int J Cancer; 2019 Oct; 145(7):1902-1912. PubMed ID: 30859564
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Genotranscriptomic meta-analysis of the CHD family chromatin remodelers in human cancers - initial evidence of an oncogenic role for CHD7.
    Chu X; Guo X; Jiang Y; Yu H; Liu L; Shan W; Yang ZQ
    Mol Oncol; 2017 Oct; 11(10):1348-1360. PubMed ID: 28649742
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Circulating-free DNA Mutation Associated with Response of Targeted Therapy in Human Epidermal Growth Factor Receptor 2-positive Metastatic breast cancer.
    Ye Q; Qi F; Bian L; Zhang SH; Wang T; Jiang ZF
    Chin Med J (Engl); 2017 Mar; 130(5):522-529. PubMed ID: 28229982
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Prognostic factors in the myoepithelial-like spindle cell type of metaplastic breast cancer.
    Leo F; Bartels S; Mägel L; Framke T; Büsche G; Jonigk D; Christgen M; Lehmann U; Kreipe H
    Virchows Arch; 2016 Aug; 469(2):191-201. PubMed ID: 27220763
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Clinical and prognostic relevance of EZH2 in breast cancer: A meta-analysis.
    Wang X; Hu B; Shen H; Zhou H; Xue X; Chen Y; Chen S; Han Y; Yuan B; Zhao H; Zhi Q; Kuang Y
    Biomed Pharmacother; 2015 Oct; 75():218-25. PubMed ID: 26271144
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. CCL18-mediated down-regulation of miR98 and miR27b promotes breast cancer metastasis.
    Lin X; Chen L; Yao Y; Zhao R; Cui X; Chen J; Hou K; Zhang M; Su F; Chen J; Song E
    Oncotarget; 2015 Aug; 6(24):20485-99. PubMed ID: 26244871
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 2.